Brief: Acadia Pharmaceuticals Q1 EPS USD 0.02
06/05/2026 21:05
May 06 (Reuters) - Acadia Pharmaceuticals Q1 product sales USD 268.062 million. Q1 operating expenses USD 272.678 million Q1 pretax profit USD 3.981 million Q1 net income USD 3.637 million
Recent news on Acadia Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
Acadia's Alzheimer's psychosis drug misses main goal of mid-stage study (updated)
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry